A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer

Anticancer Research

Volumn 21, Issue 4 B, 2001, Pages 3075-3079

  Stoehlmacher, J ^a   Ghaderi, V ^a   Iqbal, S ^a   Groshen, S ^a   Tsao Wei, D ^a   Park, D ^a   Lenz, H J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Colorectal tumor; DNA repair; Drug resistance; Oxaliplatin; Polymorphism; X ray repair cross complementing gene 1

Indexed keywords

ARGININE; DNA; FLUOROURACIL; GENE PRODUCT; GLUTAMINE; OXALIPLATIN; PLATINUM DERIVATIVE; PROTEIN XRCC1; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; EXON; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CODON; COLORECTAL NEOPLASMS; DNA DAMAGE; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; FLUOROURACIL; GENOTYPE; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035174375     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Requirement for the Xrcc1 DNA base excision repair gene during early mouse development
2. Assignment of a human DNA-repair gene associated with sister chromatid exchange to chromosome 19
3. Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange
4. A Chinese hamster ovary cell mutant (EM-C11) with sensitivity to simple alkylating agents and a very high level of sister chromatid exchangees
5. XRCC1 polymorphisms: Effects on aflatoxin B1-DNA Adducts and glycophorin A variant frequency
6. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in hman blood mononuclear cell
7. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt
8. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung
9. Genetic polymorphism of DNA repair in human prostate cancer risk
10. ERCC1 mRNA levels complement thymidylate synthase mRNA levels predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy
11. Oxaliplatin: Mechanism of action and antineoplastic activity
12. Nonparametric estimation form incomplete observations
13. Oxaliplatin plus 5-fluorouracil: Clinical experience in patients with advanced colorectal cancer
14. Kinetic analysis of the in vitro binding of radioactive cis- and trans-dichlorodiamminplatinum(II) to DNA
15. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage
16. Structure of an XRCC1 BRCT domain: A new protein- protein interaction module
17. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells
18. Cisplatin and adriamycin resistance are associated with MutLα and mismatch repair deficiency in an ovarian tumor cell line
19. Emcient nucleotide excision repair of cisplatin, oxaliplatin, and bis-acetoammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts
20. Base excision repair of oxidative DNA damage activated by XPG protein